A series of 12 new thiazolidine-2,4-dione derivatives were obtained by microwave-assisted synthesis. All compounds were physicochemically characterized by quantitative elemental C, H, N, S analysis and spectral data (mass spectrometry [MS], infrared [IR], and nuclear magnetic resonance [NMR]), with the results being in agreement with the expected data. An in vitro screening performed on Candida albicans ATCC 10231 showed their moderate antifungal activity, which was further investigated by determining the minimum inhibitory concentration and minimum fungicidal concentration values for the most active compounds on four strains of Candida. The molecular docking studies, performed against a fungal lanosterol 14α-demethylase, emphasized the importance of different molecular fragments in the compounds' structures for their antifungal activity. The synthesized compounds were subjected to in silico screening for the prediction of their absorption, distribution, metabolism, excretion, and toxicity (ADMET) and molecular properties. The results of the antifungal activity assays, docking study, and ADMET predictions revealed that the synthesized compounds are potential anti-Candida agents that might act by interacting with the fungal lanosterol 14α-demethylase and could be further optimized and developed as antifungal agents.
Introduction
Heterocyclic compounds containing nitrogen, oxygen, and sulfur atoms are known for exhibiting a wide spectrum of pharmacological activities. [1] [2] [3] [4] [5] Since the anticonvulsant, antimicrobial, and antihyperglycemic potential of several thiazolidine-2,4-dione-bearing compounds was reported, this moiety has been intensively studied in the last decades. 3 Thiazolidine-2,4-dione derivatives have been also identified as potential inhibitors of lanosterol 14α-demethylase. 4 Infections caused by invasive and pathogenic fungi, especially in high-risk and immunocompromised patients, represent some of the most life-threatening diseases worldwide. [5] [6] [7] The opportunistic yeasts that belong to the Candida genus are the most common human fungal pathogens. Antifungals belonging to the azoles class, such as fluconazole, which act by inhibiting the fungal lanosterol 14α-demethylase, are extensively used for fungal infection therapy. Limited therapeutic choices for the control of fungal diseases, the systemic toxicity, and the pharmacokinetic deficiencies of some authorized antifungals, combined with the continuously increasing risk of antifungal resistance, resulted in the need for developing novel antifungal agents. 5, 7, 8 excretion, and toxicity (ADMET) properties from the first steps of drug discovery. Suboptimal pharmacokinetic properties and increased toxicity can lead to a drug's failure in the development phases; therefore, in silico prediction of ADMET properties of new drug candidates could be useful for eliminating the molecules that will probably fail in the early stages of drug development.
Based on these facts and as a continuation of our research on heterocyclic compounds bearing sulfur and nitrogen atoms, we designed and synthesized under microwave irradiation new thiazolidine-2,4-dione derivatives as potential antifungal agents. The compounds' antifungal properties were assessed in vitro against several fungal strains, and their affinity toward the fungal lanosterol 14α-demethylase and their ADMET properties were determined in silico in order to select potential lead compounds that could be further optimized into potential anti-Candida agents.
Materials and Methods

Chemistry
Reagents and solvents used for synthesis were of analyticalgrade purity and purchased from Alfa Aesar (Karlsruhe, Germany) and Merck (Darmstadt, Germany). Microwaveassisted synthesis was performed using a CEM Discover BenchMate reactor, in open-vessel mode, under a condenser and with magnetic stirring. The synthetic route (Fig. 1) , followed to obtain the series of compounds 7a-f and 8a-f and the intermediates 4 and 5, is based on modified protocols that were previously reported in the literature. 1, 3, 10 The chemical syntheses were monitored by thin-layer chromatography. The melting points were determined using an electrothermal melting point meter in a glass open capillary. Elemental analysis of the final compounds 7a-f and 8a-f was performed on a Vario El CHNS instrument. Mass spectrometry (MS) analyses were performed on an Agilent 1100 series in positive ionization with an Agilent Ion Trap SL mass spectrometer (Agilent, Santa Clara, CA). Infrared (IR) spectra were recorded using a Jasco FT/IR 6100 spectrometer (Jasco, Easton, MD), after compression under vacuum in anhydrous KBr.
1 H-NMR analyses were performed in DMSO-d 6 (δ H = 2.51 ppm) as solvent on a Bruker Avance nuclear magnetic resonance (NMR) spectrometer (Karlsruhe, Germany), operating at 500 MHz, with tetramethylsilane (TMS) as the internal standard. 13 C-NMR spectra were recorded on a Bruker Avance NMR spectrometer, operating at 125 MHz, in DMSO-d 6 , using a Waltz-16 decoupling scheme, with TMS as the internal standard.
The protocols for the synthesis of 5-(hydroxybenzylidene)thiazolidine-2,4-diones (4 and 5) and 3,5-disubstituted thiazolidine-2,4-diones (7a-f and 8a-f) are presented in the Supplementary Material.
Antifungal Assay
Stock solutions (1 mg/mL) were prepared by dissolving the test compounds 4, 5, 7a-f, and 8a-f and the reference antifungal (fluconazole) in sterile DMSO. These solutions were stored in a refrigerator at 4 °C. The solvent used (DMSO) showed no inhibition of fungal growth and was used as negative control.
Determination of Inhibition Zone Diameters. The antifungal screening was based on the agar disk diffusion method against Candida albicans ATCC 10231, according to the guidelines of the National Committee for Clinical Laboratory Standards. 11 Fifty microliters of each stock solution corresponding to 50 µg of each compound in DMSO was applied in 6 mm diameter wells cut from agar. Plates inoculated with fungus were incubated for 48 h at 37 °C. The anti-Candida effect of the tested compounds was assessed by measuring the diameter of the inhibition zone. All tests were performed in triplicate, and the average was taken as the final reading.
Determination of Minimum Inhibitory Concentration and Minimum Fungicidal Concentration Values.
For the compounds that exhibited the best in vitro anti-Candida activity through the screening assay using the diffusimetric method, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were determined.
The microorganisms used for this assay were obtained from the University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania. The MIC and MFC values were determined against cultures of C. albicans ATCC 10231, C. albicans ATCC 18804, Candida krusei ATCC 6258, and Candida parapsilosis ATCC 22019. Fluconazole was used as reference antifungal.
Antifungal activity was tested by using the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, 12 following a previously reported protocol. 13 The growth control, sterility control, and control of antifungal compounds were used. The MIC was defined as the lowest concentration required for arresting the growth of fungi. The MFC was defined as the lowest concentration of the agent at which no colonies are observed. All MIC and MFC experiments were repeated three times.
Statistical Analysis
The results of the inhibition zone diameter determination assay were expressed as mean ± standard deviation (SD) of three independent experiments. Statistical comparisons between groups were made using one-way analysis of variance (ANOVA). A value of p < 0.05 was considered to be statistically significant. Analysis was performed using the R environment for statistical computing and graphics, version 3.2.3.
Molecular Docking Study
The molecular docking study was carried out using AutoDock 4.2 14 against a fungal lanosterol 14α-demethylase. A validated experimental structure of lanosterol 14α-demethylase isolated from C. albicans, taken from the Protein Data Bank (PDB ID: 5-FSA), was used as a target. Compounds were docked in the active site of the enzyme, in a cubic space, with edges equal to 75 points. AutoDock searched for 50 conformations. The cluster inclusion criteria of the resulting poses were set to a 2 Å root mean square deviation limit. The search space was defined by center Cartesian coordinates x = 192.556, y = 1.102, and z = 38.147. Files of ligands and macromolecules were prepared using a previously reported protocol. 6, 13 The charge of the iron atom from heme was set to +2.
ADMET and Molecular Property Predictions
The new compounds were subjected to a theoretical in silico ADMET prediction study using the web tool SwissADME (http://www.swissadme.ch/), taking into account the Lipinski rule of 5 (RO5).
We have assessed the topological polar surface area (TPSA) 15 and the logarithm of the compound partition coefficient between n-octanol and water (LogP), 16, 17 important descriptors in the prediction of bioavailability and the passive transport of an active compound by the blood-brain barrier. 18 Bioavailability is highly multifactorial but is primarily driven by gastrointestinal absorption. 13 Solubility is an important aspect in designing new molecules and was computed. 19 Being a substrate to P-glycoprotein or an inhibitor of various CYP isoenzymes was computed by built-in functions of SwissADME.
Results and Discussion
Chemistry
The structures of the synthesized compounds were confirmed by elemental analysis and spectral data ( 1 H-NMR, 13 in an alkaline medium, we obtained the disubstituted compounds (phenolic oxygen and thiazolidine-2,4-dione nitrogen) in only one step.
In the 1 H-NMR spectra of the final compounds 7a-f and 8a-f, the absence of a singlet signal of one proton near 12.50 and 9.5 ppm confirmed that N-alkylation and O-alkylation were successful. Furthermore, the disappearance in the IR spectra of a broad band near 3424-3416 cm -1 , corresponding to the stretching of the phenolic O-H bond, and the appearance of two signals between 1287-1227 and 1048-1011 cm -1 , corresponding to alkyl-aryl ether asymmetric and symmetric stretching, confirmed that the O-alkylation of the intermediate compounds was successful. The disappearance of the signal corresponding to the N-H bond from the thiazolidine-2,4-dione confirmed that the N-alkylation reaction took place. The mass spectra of the final compounds 7a-f and 8a-f revealed the correct molecular ion peaks [M+H] + . The 1 H-NMR spectra is consistent with the expected data. The 1 H-NMR spectra showed one singlet for the methylidene proton between 7.83 and 7.89 ppm. The 13 C-NMR spectra of the synthesized compounds were consistent with the proposed structures. All spectral data and elemental C, H, N, and S analyses confirmed the structures of the title compounds 7a-f and 8a-f.
Antifungal Activity
Determination of Inhibition Zone Diameters. The results of the antifungal activity screening of compounds 4, 5, 7a-f, and 8a-f are presented in Table 1 .
Both intermediate compounds 4 and 5 had an inhibition diameter equal to 12 mm and are considered with weak antifungal activity. The final compounds 7a-f and 8a-f displayed higher inhibition zone diameters than both intermediates 4 and 5, suggesting that the dialkylation of 5-(hydroxybenzylidene)thiazolidine-2,4-diones 4 and 5 is favorable to the antifungal activity. The most active compounds were 7a, 7c, and 7e. All tested compounds presented lower inhibition zone diameters than fluconazole (p < 0.05).
Minimum Inhibitory Concentration and Minimum Fungicidal
Concentration. In the initial in vitro anti-Candida screening, compounds 7a, 7c, 7e, 8a, and 8e presented the best antifungal activity (Table 1) , so the MICs and MFCs of these compounds, in comparison with those of fluconazole (used as the reference antifungal), were further determined. The obtained results are presented in Table 2 . The MICs and MFCs were determined against C. albicans ATCC 10231, C. albicans ATCC 18804, C. krusei ATCC 6258, and C. parapsilosis ATCC 22019, using the broth microdilution method. The inoculum control presented growth in all concentrations, and the broth control had no growth.
The most active compound was 7a, having similar antiCandida activity as fluconazole (p < 0.05), used as the positive control. For these compounds, on all Candida strains, the MIC and MFC values were 15.62 and 31.25 µg/mL, respectively. The same MIC and MFC values were found for fluconazole. The C. parapsilosis strain used in the study seemed to be less susceptible to the tested compounds than fluconazole (p < 0.05). Substitution of intermediates 4 and 5 generally increases the anti-Candida potential. In our series, the most active compound was 7a, with an antifungal activity similar to that of fluconazole (p < 0.05), suggesting that the presence of arylcarbonylmethyl groups is more favorable to the inhibitory activity toward Candida.
The MFC/MIC ratio for all tested compounds ranged from 1 to 2, suggesting that all the synthesized thiazolidine-2,4-one derivatives could act as fungicidal agents. 20 
Molecular Docking Study
The results of the molecular docking study show the best binding affinities of the compounds in the active site of lanosterol 14α-demethylase and their consequent predicted inhibition constants ( Table 3) .
The best binding compound is considered 7a, with ΔG = -12.44 kcal/mol and, consequently, Ki = 0.76 nM. Its binding mode is presented in Supplementary Figure S1 . Disubstitution of compounds with a large residue such as R a or carboxylic such as R e is probable to give a higher inhibition potential of the enzyme.
An interesting aspect is that ligands substituted with aromatic rings have fewer conformations in the 2 Å cluster (their proposed binding modes are less homogeneous than The value obtained for each compound represents the mean of three independent measurements ± SD. The values obtained for the most active compounds are marked in bold.
those substituted with smaller alkyl moieties); thus, they have many clusters with few conformations. Also, compounds substituted in position 2 (the salicyl derivatives) bind less homogeneously and have lower binding energies in comparison with the 3-hydroxy derivatives.
The C=O groups from the substituents are important for the formation of hydrogen bonds with Ser378. The absence of ketone groups from the side chains of compounds 7f and 8f led to a lower binding affinity to the catalytic site of the enzyme due to the lack of interactions with Ser378 and the iron atom from heme. The C=O groups from thiazolidine-2,4-dione are important for the formation of hydrogen bonds with Ser378, Tyr118, and Met508. Substitution increases overall the binding affinity, compared with the parent compounds 4 and 5. The potential polar interaction between an iron atom from heme and an oxygen from the C=O bond is predicted, as shown in Supplementary Figure  S1 .
ADMET and Molecular Property Predictions
The results of virtual screening, carried out with SwissADME, for the following descriptors are presented in Table 4 : molecular weight (MW), number of rotatable bonds (RoB; the number of any single nonring bond, linked to nonterminal heavy atom-amide C-N bonds, is not considered because of their high rotational energy barrier 21 ), hydrogen bond acceptors (HBAs; the sum of all oxygen and nitrogen atoms, according to the RO5 definition 22 ), hydrogen bond donors (HBDs; the sum of all -OH and -NH, according to the RO5 definition 22 ), TPSA, and the LogP characterizing lipophilicity. The penetration of the blood-brain barrier was evaluated only based on the values predicted for MW, LogP, HBA, HBD, and TPSA, as specified in the literature. 23 All compounds passed the RO5, having MW < 500 Da, mLogP < 4.15, less than 10 HBAs, and less than 5 HBDs.
Also, all compounds passed the TPSA limit to 140 Å 2 , except 7b and 8b, which far exceeded it (160.07 Å 2 ), and 7e and 8e, which slightly exceeded it (146.51 Å 2 ). Regarding compounds' lipophilicity, it was observed that the presence of voluminous substituents (such as phenylcarbonylmethyl in compounds 7a and 8a) or ester groups (in compounds 7d and 8d) considerably increased the lipophilicity of the compounds, whereas introducing polar groups, such as amide (7b and 8b) and carboxyl (7e and 8e), led to lower values of LogP. The predicted solubility, gastrointestinal absorption, blood-brain barrier penetrability, P-glycoprotein affinity, and CYP inhibition of the synthesized compounds are summarized in Table 5 . Compounds 7a and 8a are predicted to have a poor solubility; others are predicted to be soluble or moderately soluble. Compounds that exceed the TPSA limit are predicted to have a low gastrointestinal absorption; others are predicted to have a high gastrointestinal absorption. No compound is predicted to pass the blood-brain barrier, so the risk of adverse central nervous system effects is diminished. Regarding CYP inhibition, unlike fluconazole, eight of the newly synthesized compounds presented no affinity toward CYP isoenzymes; therefore, there is a lower risk for interactions with drugs that are metabolized through CYP450 isoforms.
Conclusions
In the search for new antifungal agents, 12 novel thiazolidine-2,4-dione derivatives were synthesized by microwaveassisted synthesis and tested in vitro for their antifungal properties, against several strains of Candida, by the disk diffusion method and broth microdilution method. The structures of all synthesized compounds were confirmed by physical data, MS, 1 H-NMR, 13 C-NMR, and IR spectroscopy and quantitative elemental analyses. The synthesized compounds presented moderate to good antifungal activity that might be improved by further research studies. Compound 7a displayed an anti-Candida potential similar to that of fluconazole, used as a reference drug, against several strains of fungi. Substitution of parent compounds with large aromatic fragments with C=O groups is the most favorable substitution for anti-Candida activity.
For all the studied compounds, a lipophilicity augmentation was observed by introducing ester groups or phenylcarbonyloxomethyl rests. The thorough virtual screening carried out for ADMET profiling of the thiazolidine-2,4-dione derivatives led to the conclusion that based on the predicted values of physicochemical descriptors, all derivatives are small molecules with good predictions for oral bioavailability according to RO5, thus making them suitable for systemic use. An absence of blood-brain barrier penetrability was also forecasted for all the synthesized compounds, thus making them less likely to possess central nervous system adverse effects.
